|
Asston Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
71.50 Cr.
|
P/BV
|
1.85
|
Book Value (Rs.)
|
45.39
|
|
52 Week High/Low (Rs.)
|
126/75
|
FV/ML
|
10/1000
|
P/E(X)
|
16.54
|
|
Bookclosure
|
|
EPS (Rs.)
|
5.08
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 15.42 | 9.07 | 15.97 |
| Total Income From Operations | 15.42 | 9.07 | 15.97 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 9.01 | 1.28 | 9.90 |
| Employees Cost | 0.61 | 1.02 | 0.48 |
| Depreciation | 0.07 | 0.06 | 0.02 |
| Other Expenses | 3.56 | 2.87 | 3.33 |
| Total Expenses | 13.25 | 5.23 | 13.73 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 2.16 | 3.84 | 2.24 |
| Other Income | 1.49 | -0.07 | 0.64 |
| P/L Before Interest, Excpt. Items & Tax | 3.65 | 3.77 | 2.88 |
| Interest | 0.28 | 0.53 | 0.42 |
| P/L Before Exceptional Items & Tax | 3.37 | 3.24 | 2.46 |
| Exceptional Items | -3.35 | 0.00 | 0.00 |
| P/L Before Tax | 0.03 | 3.24 | 2.46 |
| Tax | -0.01 | 0.82 | 0.56 |
| P/L After Tax from Ordinary Activities | 0.03 | 2.42 | 1.90 |
| Net Profit/Loss For the Period | 0.03 | 2.42 | 1.90 |
| | | | |
| Equity Share Capital | 8.51 | 6.27 | 6.27 |
| Reserves And Surplus | 0.00 | 4.45 | 0.00 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | 0.05 | 3.87 | 3.03 |
| Diluted EPS (Rs.) | 0.05 | 3.86 | 3.03 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | 0.05 | 3.87 | 3.03 |
| Diluted EPS (Rs.) | 0.05 | 0.00 | 3.03 |
| | | | |
| PBITOE Margin (%) | 14.03 | 42.29 | 14.04 |
| PBTE Margin (%) | 21.88 | 35.73 | 15.39 |
| PBT Margin (%) | 0.16 | 35.73 | 15.39 |
| PAT Margin (%) | 0.22 | 26.72 | 11.90 |
